Answers are grounded in this paper and cite their sources.
Interleukin-15 (IL-15) transgenic mice which had been inoculated with Mycobacterium bovis bacillus Calmette-Guérin (BCG) 24 weeks previously showed resistance against airborne infection with Mycobacterium tuberculosis H37Rv accompanied by an increased CD8(+)-Tc1-cell response. IL-15 may be used as an immune adjuvant given with BCG vaccination to enhance its biologic efficacy.
No takes yet. Share an insight, caveat, or question.
Umemura et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: